1. Home
  2. ZIM vs ADPT Comparison

ZIM vs ADPT Comparison

Compare ZIM & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ZIM Integrated Shipping Services Ltd.

ZIM

ZIM Integrated Shipping Services Ltd.

HOLD

Current Price

$20.20

Market Cap

2.6B

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$16.40

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZIM
ADPT
Founded
1945
2009
Country
Israel
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
ZIM
ADPT
Price
$20.20
$16.40
Analyst Decision
Sell
Strong Buy
Analyst Count
5
10
Target Price
$15.04
$16.70
AVG Volume (30 Days)
3.3M
1.9M
Earning Date
03-11-2026
02-05-2026
Dividend Yield
19.88%
N/A
EPS Growth
N/A
N/A
EPS
8.31
N/A
Revenue
$7,587,100,000.00
$252,754,000.00
Revenue This Year
N/A
$50.86
Revenue Next Year
N/A
$0.53
P/E Ratio
$2.59
N/A
Revenue Growth
1.63
42.57
52 Week Low
$11.04
$6.26
52 Week High
$24.47
$20.76

Technical Indicators

Market Signals
Indicator
ZIM
ADPT
Relative Strength Index (RSI) 40.69 40.38
Support Level $22.51 $17.65
Resistance Level $22.61 $19.80
Average True Range (ATR) 0.97 1.08
MACD -0.32 -0.21
Stochastic Oscillator 3.64 0.87

Price Performance

Historical Comparison
ZIM
ADPT

About ZIM ZIM Integrated Shipping Services Ltd.

ZIM Integrated Shipping Services Ltd is an asset-light container liner shipping company. It offers tailored services, including land transportation and logistical services, specialized shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. Its services include Cargo Services, Digital Services, Schedules, and Shipping Trades and Lines. Geographically, it derives a majority of its revenue from the Pacific trade region.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: